Ms. Michelle Chen, Ph.D., is the Chief Business Officer of Insilico Medicine. She has over 20 years of experience in business development, R&D and commercialization. She was the former SVP and head of Corporate Development and Discovery Business Development at WuXi Biologics. She was also the former Executive Director of Business Development, Search and Evaluation at Merck and the biotechnology executive role at Roche. She received her Ph.D. from the University of Washington.